![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » WOCKHARDT INKS DEAL WITH BRITISH FIRM
WOCKHARDT INKS DEAL WITH BRITISH FIRM
June 5, 2006
Leading pharmaceutical manufacturer Wockhardt Monday signed an in-licensing agreement with a British company specialising in dermatology to market a patented product for the treatment of a pigmentation disorder.
Monsters and Critics (http://news.monstersandcritics.com/business/article_1169805.php/Wockhardt_inks_deal_with_British_firm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct